CCL2 and amyotrophic lateral sclerosis: However, the small heterogeneity in some subgroups may be due to the limited number of studies, given that data were pooled from four studies comparing CSF MCP-1 levels between ALS patients and HC subjects, and four studies used non-ELISA assay to compare CSF MCP-1 levels between ALS patients and controls.